<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages readOnly="true">en</availableLanguages>
  <rcn>239584</rcn>
  <id>101071749</id>
  <acronym>CanceRusolution</acronym>
  <teaser>R-nuucell is developing a new drug to treat Triple Negative Breast Cancer (TNBC) for which there is not any specific and efficient treatment in the market, making this disease an unmet clinical need.The aggressivity of TNBC is due to the easiness of its metastization expanding...</teaser>
  <objective>R-nuucell is developing a new drug to treat Triple Negative Breast Cancer (TNBC) for which there is not any specific and efficient treatment in the market, making this disease an unmet clinical need.
The aggressivity of TNBC is due to the easiness of its metastization expanding the cancer through the body inevitably leading to death. So far, we gathered a set of results showing the antimetastatic potential of our new drug which mode of action would, conceptually, be able to eliminate the deadliest feature of cancer cells – their ability to invade and metastasize. This happens because the target of our drug is the cells’ foundation (ie the cytoskeleton). Thus, destroying the cytoskeleton of cells is like shaking the foundations of a house, it will be tumble-down!
With the Women TechEU program we will consolidate the proof-of-concept of the drug’s efficiency against metastases through two sets of in vivo studies in nude mice, and we will start the pre-clinical studies by performing pharmacokinetics (drug absorption, distribution, metabolism and excretion). Also, in view of the natural future development of our drug we will start to develop its synthesis scale-up from the milligram to the multigram scale. 
Women TechEU program mentoring and coaching will be also key to consolidate our business plan and to approach partners and investors towards a fundraising Level A in the near future. This level of funding (~1 M€) will enable to finish our pre-clinical studies and place R-nuucell in the position to license its international patent, one of the company’s assets (PT108082B, EA038640B1, EP3227307B1, CN107466297B, JP6726678B2, US15/533,289, under examination on Canada, Brazil and India), to a pharmaceutical company using a “business-to-business” strategy.</objective>
  <title>A NEW DRUG TO TREAT TRIPLE NEGATIVE BREAST CANCER</title>
  <keywords>metastatic cancer,  ruthenium drug,  targeted therapy</keywords>
  <totalCost>0</totalCost>
  <ecMaxContribution>75000</ecMaxContribution>
  <startDate>2022-06-01</startDate>
  <endDate>2023-05-31</endDate>
  <ecSignatureDate>2022-05-24</ecSignatureDate>
  <duration>12</duration>
  <status>CLOSED</status>
  <identifiers>
    <grantDoi>10.3030/101071749</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2022-06-17 10:31:42</sourceUpdateDate>
  <contentCreationDate readOnly="true">2022-08-10 17:33:13</contentCreationDate>
  <contentUpdateDate>2025-09-01 22:53:50</contentUpdateDate>
  <lastUpdateDate readOnly="true">2025-11-03 09:43:36</lastUpdateDate>
  <relations>
    <associations>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>436715</rcn>
        <id>436715-a-novel-anti-metastatic-treatment-against-triple-negative-breast-cancer</id>
        <title>A novel anti-metastatic treatment against triple negative breast cancer</title>
        <contentUpdateDate>2022-10-31 17:44:07</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/projectDescription</code>
              <title>Project description</title>
              <description>Article: description of linked project written by editorial team</description>
              <displayCode readOnly="true">/Project description</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
        </relations>
      </article>
      <article source="editorial" type="relatedArticle">
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <rcn>446734</rcn>
        <id>446734-novel-drug-offers-hope-in-battle-against-breast-cancer</id>
        <title>Novel drug offers hope in battle against breast cancer</title>
        <teaser>Promising results of a new ‘metallodrug’ could lead to an effective new treatment against a particularly aggressive form of breast cancer.</teaser>
        <contentUpdateDate>2023-10-06 14:39:45</contentUpdateDate>
        <relations>
          <categories>
            <category classification="applicationDomain" type="isApplicableIn">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/health</code>
              <title>Health</title>
              <displayCode readOnly="true">/Health</displayCode>
            </category>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/brief</code>
              <title>Result in Brief</title>
              <description>Article: Classic and enhanced</description>
              <displayCode readOnly="true">/Result in Brief</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/editorial</code>
              <title>CORDIS Editorial</title>
              <description>Written by CORDIS</description>
              <displayCode readOnly="true">/CORDIS Editorial</displayCode>
            </category>
          </categories>
          <associations>
            <webItem source="editorial" represents="article" type="relatedImage">
              <language>any</language>
              <availableLanguages readOnly="true">any</availableLanguages>
              <uri>/docs/article/images/2023-10/446734.jpg</uri>
              <mimetype readOnly="true">image/jpeg</mimetype>
              <size readOnly="true">116834</size>
            </webItem>
          </associations>
        </relations>
      </article>
      <call source="corda" type="relatedMasterCall">
        <rcn>55405</rcn>
        <title>HORIZON-EIE-2021-SCALEUP-01</title>
        <identifier>HORIZON-EIE-2021-SCALEUP-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>55405</rcn>
        <title>HORIZON-EIE-2021-SCALEUP-01</title>
        <identifier>HORIZON-EIE-2021-SCALEUP-01</identifier>
      </call>
      <organization source="corda" order="1" ecContribution="75000" terminated="false" sme="true" netEcContribution="75000" totalCost="0" type="coordinator">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1975338</rcn>
        <id>888729812</id>
        <vatNumber>PT516289292</vatNumber>
        <legalName>SOMETHING IN HANDS - INVESTIGACAOCIENTIFICA, LDA</legalName>
        <address>
          <street>EDIFICIO TEC LABS, CAMPUS DA FCUL</street>
          <city>Lisboa</city>
          <postalCode>1749-016</postalCode>
          <country>PT</country>
          <geolocation>38.7051749,-9.2306212</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PRC</code>
              <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
              <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Portugal</name>
              <rcn>427199016</rcn>
              <nutsCode>PT</nutsCode>
              <euCode>PT</euCode>
              <isoCode>PT</isoCode>
            </region>
            <region type="relatedRegion">
              <name>Portugal</name>
              <rcn>427199016</rcn>
              <nutsCode>PT</nutsCode>
              <euCode>PT</euCode>
              <isoCode>PT</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme source="corda" uniqueProgrammePart="true" type="relatedLegalBasis">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>705796</rcn>
        <id>HORIZON.3.2</id>
        <code>HORIZON.3.2</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.3.2</pga>
        <title>European innovation ecosystems</title>
        <parent>
          <programme>
            <rcn>705791</rcn>
            <code>HORIZON.3</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode readOnly="true">/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme source="corda" type="relatedTopic">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>706035</rcn>
        <id>HORIZON_HORIZON-EIE-2021-SCALEUP-01-03</id>
        <code>HORIZON-EIE-2021-SCALEUP-01-03</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>Women TechEU</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode readOnly="true">/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454386</code>
              <title>Market-creating innovation</title>
              <displayCode readOnly="true">/Market-creating innovation</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453573</code>
              <title>Innovation and diversity (e.g. gender)</title>
              <displayCode readOnly="true">/Innovation and diversity (e.g. gender)</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453477</code>
              <title>Industrial dynamics</title>
              <displayCode readOnly="true">/Industrial dynamics</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453576</code>
              <title>Innovation management</title>
              <displayCode readOnly="true">/Innovation management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452634</code>
              <title>Gender in innovation development</title>
              <displayCode readOnly="true">/Gender in innovation development</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43452100</code>
              <title><![CDATA[Financial & Investment management]]></title>
              <displayCode readOnly="true"><![CDATA[/Financial & Investment management]]></displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43454392</code>
              <title>Marketing management</title>
              <displayCode readOnly="true">/Marketing management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43458202</code>
              <title>Technology management</title>
              <displayCode readOnly="true">/Technology management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43450026</code>
              <title>Business management</title>
              <displayCode readOnly="true">/Business management</displayCode>
            </category>
            <category classification="topicKeyword" type="isAbout">
              <language>en</language>
              <availableLanguages readOnly="true">en</availableLanguages>
              <code>/43453837</code>
              <title>IPR management</title>
              <displayCode readOnly="true">/IPR management</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>977166</rcn>
        <id>101071749_PSHORIZON</id>
        <title>Periodic Reporting for period 1 - CanceRusolution (A NEW DRUG TO TREAT TRIPLE NEGATIVE BREAST CANCER)</title>
        <teaser>Survival rates for patients with Triple Negative Breast Cancer (TNBC) are as low as 11%. This type of breast cancer is more aggressive and with a poor prognosis since, at a very early stage, it develops metastases, i.e., secondary tumors in other organs. While patients with...</teaser>
        <description>periodic</description>
        <sourceUpdateDate>2023-09-04 19:59:11</sourceUpdateDate>
        <contentUpdateDate>2023-09-29 15:41:57</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/pubsum</code>
              <title>Report Summary</title>
              <description>Result: Publishable summary (FP7 SESAM) and Summary for publication (H2020 SyGMa)</description>
              <displayCode readOnly="true">/Report Summary</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </result>
      <result source="corda" type="relatedResult">
        <availableLanguages readOnly="true">en</availableLanguages>
        <rcn>1237407</rcn>
        <id>101071749_F683506EFC93E284957D109420BF3366_IPRHORIZON</id>
        <title>MACROMOLECULAR TRANSITION METAL COMPLEXES FOR TREATMENT OF CANCER AND PROCESS FOR THEIR PREPARATION</title>
        <details>
          <iprAwarded>EP</iprAwarded>
          <iprDate>2015-12-07</iprDate>
          <iprNumber>15820592</iprNumber>
          <iprPrefix>EP</iprPrefix>
        </details>
        <sourceUpdateDate>2025-01-10 11:51:31</sourceUpdateDate>
        <contentUpdateDate>2025-01-10 11:51:31</contentUpdateDate>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/ipr</code>
              <title>Intellectual Property Rights</title>
              <description>Result: Intellectual property rights linked to the results of EU funded research (FP7 onwards)</description>
              <displayCode readOnly="true">/Intellectual Property Rights</displayCode>
            </category>
            <category classification="iprType" type="isRegisteredAs">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/PATENT</code>
              <title>Patent</title>
              <displayCode readOnly="true">/Patent</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode readOnly="true">/CORDA</displayCode>
            </category>
          </categories>
          <associations>
            <organization source="corda" type="isRegisteredBy">
              <availableLanguages readOnly="true">en</availableLanguages>
              <rcn>1975338</rcn>
              <id>888729812</id>
              <vatNumber>PT516289292</vatNumber>
              <legalName>SOMETHING IN HANDS - INVESTIGACAOCIENTIFICA, LDA</legalName>
              <address>
                <street>EDIFICIO TEC LABS, CAMPUS DA FCUL</street>
                <city>Lisboa</city>
                <postalCode>1749-016</postalCode>
                <country>PT</country>
                <geolocation>38.7051749,-9.2306212</geolocation>
              </address>
              <relations>
                <categories>
                  <category classification="organizationActivityType" type="relatedOrganizationActivityType">
                    <language>en</language>
                    <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
                    <code>/PRC</code>
                    <title>Private for-profit entities (excluding Higher or Secondary Education Establishments)</title>
                    <displayCode readOnly="true">/Private for-profit entities (excluding Higher or Secondary Education Establishments)</displayCode>
                  </category>
                </categories>
                <regions>
                  <region type="relatedNutsCode">
                    <name>Portugal</name>
                    <rcn>427199016</rcn>
                    <nutsCode>PT</nutsCode>
                    <euCode>PT</euCode>
                    <isoCode>PT</isoCode>
                  </region>
                  <region type="relatedRegion">
                    <name>Portugal</name>
                    <rcn>427199016</rcn>
                    <nutsCode>PT</nutsCode>
                    <euCode>PT</euCode>
                    <isoCode>PT</isoCode>
                  </region>
                </regions>
              </relations>
            </organization>
          </associations>
        </relations>
      </result>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode readOnly="true">/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/39/225</code>
        <title>oncology</title>
        <displayCode readOnly="true">/medical and health sciences/clinical medicine/oncology</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/21/35/159/647</code>
        <title>pharmacokinetics</title>
        <displayCode readOnly="true">/medical and health sciences/basic medicine/pharmacology and pharmacy/pharmacokinetics</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode readOnly="true">/Digital agenda</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode readOnly="true">/Clean air</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode readOnly="true">/Artificial intelligence</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode readOnly="true">/Climate action</displayCode>
      </category>
      <category weight="0" classification="policyPriorities" type="marker">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode readOnly="true">/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages readOnly="true">en</availableLanguages>
        <code>/HORIZON-CSA</code>
        <title>HORIZON Coordination and Support Actions</title>
        <description>HORIZON Coordination and Support Actions</description>
        <displayCode readOnly="true">/HORIZON Coordination and Support Actions</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages readOnly="true">de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode readOnly="true">/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>
